447 March Road
ON K2K 1X8
Canada - Map
Nordion Inc., a health science company, provides various products and services for the prevention, diagnosis, and treatment of diseases worldwide. The company operates in two segments, Sterilization Technologies and Medical Isotopes. The Sterilization Technologies segment offers Cobalt-60, a radioactive metal that emits radiation and sterilizes items by destroying contaminating micro-organisms; and dosimetry and professional services, as well as designs, constructs, and maintains commercial gamma sterilization systems. The Medical Isotopes segment provides various products that are used in the diagnosis and treatment of diseases, including cardiac and neurological conditions, and various types of cancer. It offers Molybdenum-99, which decays into Technetium-99, a diagnostic that is used in nuclear medical procedures; Xenon-133 used in lung scans; Iodine-131 to treat hyperthyroidism, thyroid cancer, and non-Hodgkins lymphoma; Iodine-125 to treat prostate cancer; and Yttrium-90 to treat liver cancer and non-Hodgkins lymphoma. This segment also provides cyclotron isotopes, such as Iodine-123 to diagnose thyroid disease; Thallium-201 to diagnose and assess risk of coronary artery heart disease; Palladium-103 for treating prostate cancer; Strontium-82 for cardiac imaging; and Indium-111 and Gallium-67 to diagnose cancer, as well as offers radiopharmaceutical and contract manufacturing services. Nordion Inc. serves radiopharmaceutical and pharmaceutical manufacturers, biotechnology companies, manufacturers of medical supplies and devices, contract sterilizers, hospitals, and academic and government institutions, as well as to food and consumer goods industries. The company was formerly known as MDS Inc. and changed its name to Nordion Inc. in November 2010. Nordion Inc. was founded in 1946 and is headquartered in Ottawa, Canada. As of August 6, 2014, Nordion Inc. operates as a subsidiary of Sterigenics International, Inc.
|Mr. Steven M. West ,
Chief Exec. Officer, Pres, Non Independent Director and Member of Technology Committee
|Mr. George Peter Dans ,
Chief Financial Officer and Sr. VP
|Mr. S. Grant Gardiner ,
Sr. VP, Gen. Counsel and Corp. Sec.
|Mr. Christopher Ashwood ,
Sr. Vice-Pres of Corp. Services
|Mr. Scott McIntosh ,
Chief Operating Officer of Specialty Isotopes and Gen. Mang. of Sterilization Technologies
|Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.|
|Currency in CAD.|